Integrated Community Case Management (ICCM) Delivered by Village Health Teams in Bushenyi District in Uganda

NCT ID: NCT02046018

Last Updated: 2014-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-10-31

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In Sub-Saharan Africa (SSA), many children die from diarrhoea, acute respiratory illness (ARI) and malaria, despite well- recognized, inexpensive and highly effective treatments, since health access and human resources are limited. Healthy Child Uganda (HCU) is a Ugandan-Canadian partnership that since 2003, has developed, implemented and evaluated a Village Health Volunteer (VHV) program in 175 rural villages. Volunteers, selected by peers, provide health education and refer sick children. Volunteer retention (94%) and significant decreases in child deaths are remarkable. Now, HCU wonders whether VHV scope can extend to provide treatment for sick children using Oral Rehydration Salts (ORS)/Zinc, antibiotics, and antimalarials. Use of lay providers in this capacity, called integrated community case management (iCCM), has been proposed as a potential inexpensive solution to SSA's human health resource crisis.

PRIMARY QUESTION: In rural southwest Uganda, can iCCM provided by lay volunteers, improve the proportion of children with diarrhoea receiving ORS/Zn, ARI receiving antibiotics, and fever/malaria receiving antimalarials? Secondary study questions consider VHV capacity to prescribe appropriate drug, dose, duration; iCCM acceptance by family, and VHV; VHV retention/motivation; program cost. Selected VHV will be iCCM trained then receive treatments for distribution. Qualitative and quantitative methods including household surveys, and focus groups will consider pre/post intervention differences and differences in control and intervention populations. A research short course and micro research grants (\~ $3000 to multidisciplinary groups pursuing relevant questions) will promote health system evaluation capacity. Lessons learned are critical as SSA countries move forward in planning for increased iCCM programming.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maternal and Child Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICCM delivered by VHT

Health Outcomes in Communities where VHT's were trained in ICCM and given drugs.

Group Type ACTIVE_COMPARATOR

ICCM delivered by VHT

Intervention Type OTHER

VHT's deliver ICCM to children under five in their communities

ICCM delivered by VHT with cell phone

Health Outcomes in communities with VHT's who were trained in ICCM and given cell phones

Group Type ACTIVE_COMPARATOR

ICCM delivered by VHT

Intervention Type OTHER

VHT's deliver ICCM to children under five in their communities

ICCM delivered by VHT with Cell Phone

Intervention Type OTHER

ICCM delivered to children under 5 by VHT trained in ICCM and given cell phones

Health outcomes in communities with no ICCM

Health outcomes in communities with VHT's who were not trained in ICCM

Group Type ACTIVE_COMPARATOR

No intervention

Intervention Type OTHER

VHT's selected by no ICCM training given and no drugs or cell phones.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ICCM delivered by VHT

VHT's deliver ICCM to children under five in their communities

Intervention Type OTHER

ICCM delivered by VHT with Cell Phone

ICCM delivered to children under 5 by VHT trained in ICCM and given cell phones

Intervention Type OTHER

No intervention

VHT's selected by no ICCM training given and no drugs or cell phones.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children under five (\< or =59 months)

Exclusion Criteria

* Children over five years (\> 59 Months)
Maximum Eligible Age

59 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Healthy Child Uganda

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Jenn Brenner

Clinical Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Samuel Maling

Role: PRINCIPAL_INVESTIGATOR

MUST

Celestine Barigye

Role: PRINCIPAL_INVESTIGATOR

MUST

Jerome Kabakyenga

Role: PRINCIPAL_INVESTIGATOR

MUST

References

Explore related publications, articles, or registry entries linked to this study.

Oliphant NP, Manda S, Daniels K, Odendaal WA, Besada D, Kinney M, White Johansson E, Doherty T. Integrated community case management of childhood illness in low- and middle-income countries. Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD012882. doi: 10.1002/14651858.CD012882.pub2.

Reference Type DERIVED
PMID: 33565123 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HCU_AHSI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.